Showing 3491-3500 of 5257 results for "".
- Impact of Alopecia Areata on Pediatric Patients and Their Families: Insights from a Single-Center Study in Turkeyhttps://practicaldermatology.com/news/impact-alopecia-areata-pediatric-patients-and-their-families-insights-single-center-study-turkey/2462829/Alopecia areata (AA) is known to impact the health-related quality of life (HRQoL) of affected individuals, yet there is a paucity of research focusing on its effects specifically in pediatric patients and their families. To address this gap, researchers recently conducted a single-center cross-s
- Study: Potential for Combined Laser Treating Vascular and Pigmented Lesionshttps://practicaldermatology.com/news/combined-laser-shows-potential-vascular-and-pigmented-lesions/2462743/A novel laser with cryogen cooling long-pulsed options of both 532nm and 1,064nm laser offers laser surgeons a safe and effective way to treat vascular and pigmented lesions with a single device and significantly different clinical endpoints, wrote Nicole M. Golbari, MD, of the University of Cali
- Review and Analysis: Triple-agent Fixed-dose Combo Tops Acne Treatmentshttps://practicaldermatology.com/news/comparative-effectiveness-moderate-severe-acne-treatments-systematic-review-and-network-meta-analysis/2462740/A topical triple-agent fixed-dose combination (FDC) was shown to be efficacious in comparison to other acne agents, according to result
- Study: Fractional Laser and Botox Combo Shows Promise for Pore Reductionhttps://practicaldermatology.com/news/fractional-laser-and-botox-combination-shows-promise-pore-reduction/2462733/A single session of treatment with a fractional carbon dioxide laser followed by botulinum toxin type A was associated with significant reduction of facial pores in a pilot study presented at the American Society for Laser Medicine and Surgery (ASLMS) 43rd Annual Conference on Energy-b
- Micro-Coring Could Offer Nonsurgical Option for Moderate to Severe Rhytidshttps://practicaldermatology.com/news/micro-coring-offers-nonsurgical-option-moderate-severe-rhytids/2462726/A dermal micro-coring device improved the appearance of moderate-to-severe rhytids on the cheek and lower face after two treatments, according to data from a new study presented at the American Society for Laser Medicine and Surgery 43rd Annual Conference on Energy-based Medicine and S
- Combined Ultrasound and Radiofrequency Promotes Greater Wrinkle Reductionhttps://practicaldermatology.com/news/combined-ultrasound-and-radiofrequency-promotes-greater-wrinkle-reduction/2462721/Using high-intensity focused ultrasound in conjunction with monopolar radiofrequency yielded greater skin tightening and wrinkle reduction than either modality alone, according to new data. High-intensity focused ultrasound (HIFU) and monopolar radiofrequency (RF) are both popular as non-
- Study: Cryomodulation May Curb Acne Inflammationhttps://practicaldermatology.com/news/study-cryomodulation-may-curb-acne-inflammation/2462718/Cryomodulation was associated with significant inflammation reduction in patients with acne vulgaris, based on data from a new pilot study presented at the American Society for Laser Medicine and Surgery 43rd Annual Conference on Energy-based Medicine and Science in Baltimore.
- Mechanical Micro-Coring Shows Promise for Neck Treatmenthttps://practicaldermatology.com/news/aslms-2024-mechanical-micro-coring-shows-promise-neck-treatment/2462716/Mechanical dermal micro-coring is a safe and effective option for improving skin laxity, texture, and wrinkles on the neck, based on new data appearing at the American Society for Laser Medicine and Surgery (ASLMS) 43rd Annual Conference on Energy-based Medicine and Science in Baltimor
- Deucravacitinib Improves Patient-Reported Outcomes for Psoriatic Arthritishttps://practicaldermatology.com/news/deucravacitinib-improves-patient-reported-outcomes-psoriatic-arthritis/2462540/Deucravacitinib, a TYK-2 inhibitor, was linked with significant improvements in patient-reported outcomes (PROs) in patients with active psoriatic arthritis (PsA), according to results from a phase 2 trial. To assess the effects of deucravacitinib in this patient population, the study aut
- Integrated Dermatology Appoints Tushar Ramani, MD, as CEOhttps://practicaldermatology.com/news/integrated-dermatology-appoints-tushar-ramani-md-ceo/2462493/Integrated Dermatology has announced the appointment of Tushar Ramani, MD, as the company's new chief executive officer (CEO). Dr. Ramani will be replacing Jeff Queen, who after two decades as CEO and executive chairman, is transitioning to the role of co-executive chairman of the Board alongside